Apimeds Pharmaceuticals US, Inc. Reports FY 2025 Financial Results

2026-05-04SEC Filing 10-K (0001213900-26-051139)

Please check the link below for details.

Ticker mentioned:APUS

Source:Original SEC Document ↗